oxaliplatin,sintilimab,capecitabine
eli lilly,innovent biologics
['sintilimab', 'orient-16', 'gastric', 'innovent', '$ivbxf']
$ivbxf new article : innovent releases final analysis results of orient-16: the phase 3 study of sintilimab in combination with chemotherapy for the first-line treatment of gastric cancer at the aacr annual meeting 2023 
Effortlessly track financial news and never miss an article again with https://t.co/hKE5DiO0B4. Our real-time database combines trusted financial news sources for easy access.